| Dr Belinda Jo Lopes, | |
|
1460 Maria Ln, Suite 310, Walnut Creek, CA 94596-8802 | |
| (925) 279-1120 | |
| (925) 944-2118 |
| Full Name | Dr Belinda Jo Lopes |
|---|---|
| Gender | Female |
| Speciality | Psychologist - Clinical |
| Location | 1460 Maria Ln, Walnut Creek, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093932246 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC0700X | Psychologist - Clinical | PSY17849 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Belinda Jo Lopes, 610 Old Vine Ct, Pleasant Hill, CA 94523-2164 Ph: (925) 279-1120 | Dr Belinda Jo Lopes, 1460 Maria Ln, Suite 310, Walnut Creek, CA 94596-8802 Ph: (925) 279-1120 |
News Archive
Hypothermia alone, the current standard of care, neuroprotects roughly 50 percent of newborns with moderate to severe hypoxic ischemia. Therefore, half of all affected newborns are left with developmental, cognitive and motor delays including cerebral palsy following injury.
Patients infected by COVID-19 suffer cognitive and behavioral problems lasting even 2 months post-hospital release.
Compared with their counterparts a decade ago, today's heart attack patients are receiving emergency angioplasty or clot-busting drugs to re-open clogged arteries at a far greater rate, but 10 percent of patients who could benefit from this life-saving treatment still do not receive it, according to a study published in The American Journal of Medicine by Yale and University of Michigan researchers.
The U.S. Food and Drug Administration (FDA) today cleared the OVA1(TM) Test, the first blood test that, prior to surgery, can help physicians determine if a woman is at risk for a malignant pelvic mass. OVA1 is the first FDA-cleared laboratory test that can indicate the likelihood of ovarian cancer with high sensitivity prior to biopsy or exploratory surgery, even if radiological test results fail to indicate malignancy.
Diagnosed with severe coronary artery disease, a group of patients too ill for or not responding to other treatment options decided to take part in a clinical trial testing angiogenic gene therapy to help rebuild their damaged blood vessels.
› Verified 2 days ago
Dr. Heidi Joshi, PSYD Psychologist Medicare: Accepting Medicare Assignments Practice Location: 1450 Treat Blvd # 320, Walnut Creek, CA 94597 Phone: 925-296-9880 | |
Howard P Rome Jr., PHD Psychologist Medicare: Accepting Medicare Assignments Practice Location: 450 N Wiget Ln, Walnut Creek, CA 94598 Phone: 925-482-8111 Fax: 925-482-1166 | |
Jorge Bell, Psychologist Medicare: Not Enrolled in Medicare Practice Location: 313 Lennon Ln Ste 100, Walnut Creek, CA 94598 Phone: 925-289-1090 Fax: 925-289-1239 | |
Dr. Darrell Ray Christian, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 2950 Camino Diablo, Suite 120, Walnut Creek, CA 94597 Phone: 925-935-8646 Fax: 925-935-8646 | |
Dr. Susan K. Faron, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1280 Boulevard Way Ste 206, Walnut Creek, CA 94595 Phone: 925-932-2090 | |
Katrina Domingo, PSY.D. Psychologist Medicare: Medicare Enrolled Practice Location: 710 S Broadway, Suite #209, Walnut Creek, CA 94596 Phone: 925-295-4901 | |
Zeinab Mossadeghi, Psychologist Medicare: May Accept Medicare Assignments Practice Location: 1910 Olympic Blvd Ste 220, Walnut Creek, CA 94596 Phone: 310-773-7013 |